Glutamate transporters in the biology of malignant gliomas

Malignant gliomas are relentless tumors that offer a dismal clinical prognosis. They develop many biological advantages that allow them to grow and survive in the unique environment of the brain. The glutamate transporters system xc− and excitatory amino acid transporters (EAAT) are emerging as key players in the biology and malignancy of these tumors. Gliomas manipulate glutamate transporter expression and function to alter glutamate homeostasis in the brain, which supports their own growth, invasion, and survival. As a consequence, malignant cells are able to quickly destroy and invade surrounding normal brain. Recent findings are painting a larger picture of these transporters in glioma biology, and as such are providing opportunities for clinical intervention for patients. This review will detail the current understanding of glutamate transporters in the biology of malignant gliomas and highlight some of the unique aspects of these tumors that make them so devastating and difficult to treat.

[1]  G. Svenneby.  PIG BRAIN GLUTAMINASE: PURIFICATION AND IDENTIFICATION OF DIFFERENT ENZYME FORMS , 1970, Journal of neurochemistry.

[2]  B Chance,et al.  The cellular production of hydrogen peroxide. , 1972, The Biochemical journal.

[3]  A. M. Benjamin,et al.  METABOLISM OF AMINO ACIDS AND AMMONIA IN RAT BRAIN CORTEX SLICES IN VITRO: A POSSIBLE ROLE OF AMMONIA IN BRAIN FUNCTION , 1975, Journal of neurochemistry.

[4]  M. Norenberg,et al.  Glutamine synthetase: glial localization in brain , 1977, Science.

[5]  J. Stratford,et al.  Seizures Following Intracranial Surgery: Incidence in the First Post-Operative Week , 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  G. Ronquist,et al.  Perspectives of adenylate kinase activity and glutathione concentration in cerebrospinal fluid of patients with ischemic and neoplastic brain lesions. , 1982, European neurology.

[7]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[8]  D. Bigner,et al.  Influence of glutamine on the growth of human glioma and medulloblastoma in culture. , 1985, Cancer research.

[9]  S. Bannai.  Exchange of cystine and glutamate across plasma membrane of human fibroblasts. , 1986, The Journal of biological chemistry.

[10]  S. Bannai,et al.  Induction of cystine transport activity in mouse peritoneal macrophages , 1987, The Journal of experimental medicine.

[11]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[12]  A. Meister.  Glutathione metabolism and its selective modification. , 1988, The Journal of biological chemistry.

[13]  M. Dichter,et al.  Quisqualate activates a rapidly inactivating high conductance ionic channel in hippocampal neurons. , 1989, Science.

[14]  B. Fanburg,et al.  Regulation of cellular glutathione. , 1989, The American journal of physiology.

[15]  T. Murphy,et al.  Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  D. Attwell,et al.  The release and uptake of excitatory amino acids. , 1990, Trends in pharmacological sciences.

[17]  N. Danbolt,et al.  Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain. , 1990, Biochemistry.

[18]  E. Bump,et al.  Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. , 1990, Pharmacology & therapeutics.

[19]  V. Teichberg.  Glial glutamate receptors: likely actors in brain signaling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  T. Berger,et al.  Developmental changes in the membrane current pattern, K+ buffer capacity, and morphology of glial cells in the corpus callosum slice , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  J. Storm-Mathisen,et al.  An [Na+ + K+]coupledl-glutamate transporter purified from rat brain is located in glial cell processes , 1992, Neuroscience.

[22]  R. Miledi,et al.  mRNA coding for neurotransmitter receptors in a human astrocytoma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[24]  M. During,et al.  Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain , 1993, The Lancet.

[25]  J. Portais,et al.  Glutathione, but not glutamine, is detected in 13C‐NMR spectra of perchloric acid extracts from C6 glioma cells , 1993, FEBS letters.

[26]  K. P. Lehre,et al.  A monoclonal antibody raised against an [Na+K+]coupled l‐glutamate transporter purified from rat brain confirms glial cell localization , 1993, FEBS letters.

[27]  K. Miura,et al.  Maintenance of Neuronal Glutathione by Glial Cells , 1993, Journal of neurochemistry.

[28]  D. Piani,et al.  Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons. , 1994, Journal of immunology.

[29]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[30]  Shigetada Nakanishi,et al.  Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity , 1994, Neuron.

[31]  J. Storm-Mathisen,et al.  Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  Thomas C. Südhof,et al.  The synaptic vesicle cycle: a cascade of protein–protein interactions , 1995, Nature.

[33]  Christian Steinhäuser,et al.  News on glutamate receptors in glial cells , 1996, Trends in Neurosciences.

[34]  R. Boado,et al.  Rat C6 and human astrocytic tumor cells express a neuronal type of glutamate transporter. , 1996, Brain research. Molecular brain research.

[35]  H. Kettenmann,et al.  Neuron-like physiological properties of cells from human oligodendroglial tumors , 1996, Neuroscience.

[36]  K. P. Lehre,et al.  Brain Glutamate Transporter Proteins Form Homomultimers* , 1996, The Journal of Biological Chemistry.

[37]  G. Augustine,et al.  Exocytosis: proteins and perturbations. , 1996, Annual review of pharmacology and toxicology.

[38]  F. Spinella,et al.  Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and ‐5 on astrocyte proliferation in culture , 1997, Glia.

[39]  H. Kettenmann,et al.  Action Potential‐generating Cells in Human Glioblastomas , 1997, Journal of neuropathology and experimental neurology.

[40]  P. Calabresi,et al.  Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones , 1997, British journal of pharmacology.

[41]  M. Kavanaugh,et al.  Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Masahiko Watanabe,et al.  Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. , 1997, Science.

[43]  C. Jahr,et al.  Synaptic Activation of Glutamate Transporters in Hippocampal Astrocytes , 1997, Neuron.

[44]  F A Chaudhry,et al.  The Glutamate Transporter EAAT4 in Rat Cerebellar Purkinje Cells: A Glutamate-Gated Chloride Channel Concentrated near the Synapse in Parts of the Dendritic Membrane Facing Astroglia , 1998, The Journal of Neuroscience.

[45]  M. Chamberlain,et al.  Practical guidelines for the treatment of malignant gliomas. , 1998, The Western journal of medicine.

[46]  V. Pickel,et al.  The Localization of the Brain-Specific Inorganic Phosphate Transporter Suggests a Specific Presynaptic Role in Glutamatergic Transmission , 1998, The Journal of Neuroscience.

[47]  H. Kettenmann,et al.  Glutamate receptor activation can trigger electrical activity in human glioma cells , 1998, The European journal of neuroscience.

[48]  H. Sontheimer,et al.  Glioma cells release excitotoxic concentrations of glutamate. , 1999, Cancer research.

[49]  Harald Sontheimer,et al.  Compromised Glutamate Transport in Human Glioma Cells: Reduction–Mislocalization of Sodium-Dependent Glutamate Transporters and Enhanced Activity of Cystine–Glutamate Exchange , 1999, The Journal of Neuroscience.

[50]  T. Ishii,et al.  Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins* , 1999, The Journal of Biological Chemistry.

[51]  P. Lipton,et al.  Ischemic cell death in brain neurons. , 1999, Physiological reviews.

[52]  J. Hell,et al.  Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Dunlop,et al.  Properties of excitatory amino acid transport in the human U373 astrocytoma cell line , 1999, Brain Research.

[54]  D. Copenhagen,et al.  Molecular Analysis of System N Suggests Novel Physiological Roles in Nitrogen Metabolism and Synaptic Transmission , 1999, Cell.

[55]  B. Gähwiler,et al.  Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Somogyi,et al.  Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.

[57]  L. Arckens,et al.  Expression of EAAT-4 in mammalian cerebral cortex , 2000 .

[58]  D. Attwell,et al.  Glutamate release in severe brain ischaemia is mainly by reversed uptake , 2000, Nature.

[59]  A. Schousboe,et al.  The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms , 2000, Neurochemistry International.

[60]  I. R. Whittle,et al.  The Pathogenesis of Tumour Associated Epilepsy , 2000, Acta Neurochirurgica.

[61]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[62]  R. Martindale,et al.  Structure, function, and tissue expression pattern of human SN2, a subtype of the amino acid transport system N. , 2001, Biochemical and biophysical research communications.

[63]  G Bernardi,et al.  Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons , 2001, Neuroscience.

[64]  J. Storm-Mathisen,et al.  The Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse , 2001, Neuron.

[65]  D. Pow.  Visualising the activity of the cystine‐glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate , 2001, Glia.

[66]  Y. Kanai,et al.  Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. , 2001, Biochimica et biophysica acta.

[67]  Takahiro Takano,et al.  Glutamate release promotes growth of malignant gliomas , 2001, Nature Medicine.

[68]  J. Arias-Montaño,et al.  Glutamate activates PP125FAK through AMPA/kainate receptors in Bergmann glia , 2001, Journal of neuroscience research.

[69]  W. Rzeski,et al.  Glutamate antagonists limit tumor growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Chul-ki Min,et al.  High Abundance of GluR1 mRNA and Reduced Q/R Editing of GluR2 mRNA in Individual NADPH-Diaphorase Neurons , 2001, Molecular and Cellular Neuroscience.

[71]  M Schrey,et al.  Underediting of glutamate receptor GluR-B mRNA in malignant gliomas , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Steinhäuser,et al.  Ionotropic glutamate receptors in astrocytes. , 2001, Progress in brain research.

[73]  M. Robinson,et al.  Dibutyryl‐cAMP (dbcAMP) up‐regulates astrocytic chloride‐dependent l‐[3H]glutamate transport and expression of both system xc− subunits , 2001, Journal of neurochemistry.

[74]  E. Kvamme,et al.  Kinetics and localization of brain phosphate activated glutaminase , 2001, Journal of neuroscience research.

[75]  N. Guitton,et al.  GSH level and IL-6 production increased in Sertoli cells and astrocytes after gamma irradiation. , 2002, Anticancer research.

[76]  R. Reimer,et al.  The glutamine commute , 2002, The Journal of cell biology.

[77]  K. Osen,et al.  Cell‐specific expression of the glutamine transporter SN1 suggests differences in dependence on the glutamine cycle , 2002, The European journal of neuroscience.

[78]  G. Gillespie,et al.  Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. , 2002, Cancer research.

[79]  Y. Yoshida,et al.  Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. , 2002, Nature medicine.

[80]  Matthew E. R. Butchbach,et al.  Human Glioma Cells and Undifferentiated Primary Astrocytes That Express Aberrant EAAT2 mRNA Inhibit Normal EAAT2 Protein Expression and Prevent Cell Death , 2002, Molecular and Cellular Neuroscience.

[81]  F. Nicoletti,et al.  Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells , 2003, Journal of neurochemistry.

[82]  R. Köhling,et al.  A new neurophysiological/neuropathological ex vivo model localizes the origin of glioma-associated epileptogenesis in the invasion area , 2003, Acta Neuropathologica.

[83]  B. Howard,et al.  Wnt-1 has multiple effects on the expression of glutamate transporters , 2003, Neurochemistry International.

[84]  J. Storm-Mathisen,et al.  Highly differential expression of SN1, a bidirectional glutamine transporter, in astroglia and endothelium in the developing rat brain , 2003, Glia.

[85]  A. Ortega,et al.  α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors signaling complexes in Bergmann glia , 2004, Journal of neuroscience research.

[86]  S. Bröer,et al.  Astroglial glutamine transport by system N is upregulated by glutamate , 2004, Glia.

[87]  C. Aoki,et al.  The Glutamate Transporter GLT1a Is Expressed in Excitatory Axon Terminals of Mature Hippocampal Neurons , 2004, The Journal of Neuroscience.

[88]  J. Draeger,et al.  Extracellular Glutamate and Other Metabolites in and Around RG2 Rat Glioma: An Intracerebral Microdialysis Study , 2000, Journal of Neuro-Oncology.

[89]  O. Ottersen,et al.  Effect of ischaemia and reperfusion on the extra- and intracellular distribution of glutamate, glutamine, aspartate and GABA in the rat hippocampus, with a note on the effect of the sodium channel blocker BW1003C87 , 2004, Experimental Brain Research.

[90]  Antonio Pisani,et al.  Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases , 2004, Progress in Neurobiology.

[91]  Miguel Angel Medina,et al.  Relevance of glutamine metabolism to tumor cell growth , 1992, Molecular and Cellular Biochemistry.

[92]  Jan Albrecht,et al.  Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas , 2004, Neuroreport.

[93]  Z. Wu,et al.  In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. , 2004, Clinical radiology.

[94]  B. Cubelos,et al.  Amino acid transporter SNAT5 localizes to glial cells in the rat brain , 2005, Glia.

[95]  Satoru Takahashi,et al.  Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice* , 2005, Journal of Biological Chemistry.

[96]  G. Fuller,et al.  The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. , 2005, Cancer research.

[97]  P. Rosenberg,et al.  Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization , 2005, The Journal of comparative neurology.

[98]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[99]  H. Sontheimer,et al.  Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors , 2005, The Journal of Neuroscience.

[100]  D. Fujikawa,et al.  Prolonged seizures and cellular injury: Understanding the connection , 2005, Epilepsy & Behavior.

[101]  P. Calabresi,et al.  Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons , 2005, Neuropharmacology.

[102]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[103]  N. Savaraj,et al.  Drug resistance in brain tumors , 2005, Journal of Neuro-Oncology.

[104]  P. Loehrer.  Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma , 2006 .

[105]  R. Swanson,et al.  Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse , 2006, Nature Neuroscience.

[106]  T. Murphy,et al.  Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation , 2006, The Journal of Neuroscience.

[107]  D. Schubert,et al.  Distribution of the Cystine/Glutamate Antiporter System x− c in the Brain, Kidney, and Duodenum , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[108]  Angel Ortega,et al.  Glutathione in Cancer Biology and Therapy , 2006, Critical reviews in clinical laboratory sciences.

[109]  吉田 由香里.  Serum-dependence of AMPA receptor-mediated proliferation in glioma cells , 2006 .

[110]  Chris J. McBain,et al.  The Role of the GluR2 Subunit in AMPA Receptor Function and Synaptic Plasticity , 2007, Neuron.

[111]  C. Jahr,et al.  Extracellular Glutamate Concentration in Hippocampal Slice , 2007, The Journal of Neuroscience.

[112]  J. Engele,et al.  DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells , 2007, Glia.

[113]  H. Sontheimer,et al.  Autocrine glutamate signaling promotes glioma cell invasion. , 2007, Cancer research.

[114]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[115]  E. Hermans,et al.  Glutamate‐induced glioma cell proliferation is prevented by functional expression of the glutamate transporter GLT‐1 , 2008, FEBS letters.

[116]  E. López-Bayghen,et al.  Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: Involvement of Ying-Yang 1 , 2008, Neurochemistry International.

[117]  W. Yung,et al.  Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation , 2008, Journal of Neuro-Oncology.

[118]  D. Attwell,et al.  A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: New insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2) , 2008, Neuroscience.

[119]  M. Mattson,et al.  Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease , 2008, Annals of the New York Academy of Sciences.

[120]  Harald Sontheimer,et al.  A role for glutamate in growth and invasion of primary brain tumors , 2008, Journal of neurochemistry.

[121]  Y. Michotte,et al.  Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats , 2008, Neuroreport.

[122]  P. Gout,et al.  The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases , 2008, Journal of cellular physiology.

[123]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[124]  G. Hardingham.  Coupling of the NMDA receptor to neuroprotective and neurodestructive events. , 2009, Biochemical Society transactions.

[125]  J. Maloteaux,et al.  Enhanced expression of the high affinity glutamate transporter GLT-1 in C6 glioma cells delays tumour progression in rat , 2009, Experimental Neurology.

[126]  H. Marcus,et al.  In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines , 2010, Journal of Neuro-Oncology.

[127]  Q. Zhan,et al.  Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway , 2009, Oncogene.

[128]  M. Taphoorn,et al.  Efficacy of anti-epileptic drugs in patients with gliomas and seizures , 2009, Journal of Neurology.

[129]  H. Sontheimer,et al.  Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB , 2009, Journal of neurochemistry.

[130]  Carol A Barnes,et al.  System A transporter SAT2 mediates replenishment of dendritic glutamate pools controlling retrograde signaling by glutamate. , 2009, Cerebral cortex.

[131]  T. Mikkelsen,et al.  Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  J. D. de Groot,et al.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix. , 2009, Neuro-oncology.

[133]  D. Bigner,et al.  Glioblastoma multiforme: a review of where we have been and where we are going , 2009, Expert opinion on investigational drugs.

[134]  M. Aschner,et al.  Roles of glutamine in neurotransmission. , 2010, Neuron glia biology.

[135]  H. Sontheimer,et al.  Hypoxia Increases the Dependence of Glioma Cells on Glutathione* , 2010, The Journal of Biological Chemistry.

[136]  H. Fine,et al.  Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas , 2010, Cancer.

[137]  B. Brew,et al.  Characterisation of the Expression of NMDA Receptors in Human Astrocytes , 2010, PloS one.

[138]  Sally Freels,et al.  Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. , 2010, Neuro-oncology.

[139]  J. Rothstein,et al.  Quantitative analysis of EAAT4 promoter activity in neurons and astrocytes of mouse somatic sensory cortex , 2010, Neuroscience Letters.

[140]  G. Riggins,et al.  Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. , 2010, Cancer research.

[141]  Manfred Westphal,et al.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches , 2011, Nature Reviews Neuroscience.

[142]  F. Chaudhry,et al.  Protein Kinase C-Mediated Phosphorylation of a Single Serine Residue on the Rat Glial Glutamine Transporter SN1 Governs Its Membrane Trafficking , 2011, The Journal of Neuroscience.

[143]  J. D. de Groot,et al.  Glutamate and the biology of gliomas , 2011, Glia.

[144]  P. Fisher,et al.  Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics , 2011, Journal of cellular physiology.

[145]  P. Fisher,et al.  Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. , 2011, Cancer research.

[146]  R. Stupp,et al.  Current concepts and management of glioblastoma , 2011, Annals of neurology.

[147]  G. Reifenberger,et al.  SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation , 2011, Acta Neuropathologica.

[148]  Harald Sontheimer,et al.  Glutamate Release by Primary Brain Tumors Induces Epileptic Activity , 2011, Nature Medicine.

[149]  E. Hahnen,et al.  Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas , 2011, Oncogene.

[150]  M. Bianchi,et al.  Valproic acid induces the glutamate transporter excitatory amino acid transporter-3 in human oligodendroglioma cells , 2012, Neuroscience.

[151]  A. Bjorksten,et al.  Glutamate is associated with a higher risk of seizures in patients with gliomas , 2012, Neurology.

[152]  C. Morrison,et al.  Pharmacologic Blockade of FAK Autophosphorylation Decreases Human Glioblastoma Tumor Growth and Synergizes with Temozolomide , 2012, Molecular Cancer Therapeutics.

[153]  Y. Sekino,et al.  L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation , 2012, Journal of Neuroinflammation.

[154]  L. Parada,et al.  Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells , 2012, Cell.

[155]  T. Mauro,et al.  Overexpression of Calcium-Permeable Glutamate Receptors in Glioblastoma Derived Brain Tumor Initiating Cells , 2012, PloS one.

[156]  B. Mohar,et al.  Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas , 2012, Investigational New Drugs.

[157]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[158]  H. Sontheimer,et al.  Unique biology of gliomas: challenges and opportunities , 2012, Trends in Neurosciences.

[159]  Harald Sontheimer,et al.  Human glioma cells induce hyperexcitability in cortical networks , 2012, Epilepsia.

[160]  A. Gupta,et al.  Role of glutathione in cancer pathophysiology and therapeutic interventions. , 2012, Journal of experimental therapeutics & oncology.

[161]  K. P. Lehre,et al.  The Density of EAAC1 (EAAT3) Glutamate Transporters Expressed by Neurons in the Mammalian CNS , 2012, The Journal of Neuroscience.

[162]  Y. Samuels,et al.  Molecular Pathways: Dysregulated Glutamatergic Signaling Pathways in Cancer , 2012, Clinical Cancer Research.

[163]  D. Coulter,et al.  Astrocytic regulation of glutamate homeostasis in epilepsy , 2012, Glia.

[164]  D. Pow,et al.  Alternate splicing and expression of the glutamate transporter EAAT5 in the rat retina. , 2012, Gene.

[165]  R. Dingledine,et al.  Ionotropic Glutamate Receptors: Regulation by G-Protein-Coupled Receptors , 2013, Molecular Pharmacology.

[166]  E. Ling,et al.  Glutamate receptors in microglia. , 2013, CNS & neurological disorders drug targets.

[167]  H. Wigren,et al.  Effect of glutamate receptor antagonists on migrating neural progenitor cells , 2013, The European journal of neuroscience.

[168]  C. Steinhäuser,et al.  Polarized distribution of AMPA, but not GABAA, receptors in radial glia‐like cells of the adult dentate gyrus , 2013, Glia.

[169]  Glutamate-Dependent Translational Control in Cultured Bergmann Glia Cells: eIF2α Phosphorylation , 2013, Neurochemical Research.

[170]  Luke T. Coddington,et al.  Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma. , 2013, Journal of neurosurgery.

[171]  H. Nawashiro,et al.  Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. , 2013, Neurosurgery.

[172]  P. Kalivas,et al.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. , 2013, Antioxidants & redox signaling.

[173]  M. Caba,et al.  GLAST/EAAT1‐induced Glutamine release via SNAT3 in Bergmann glial cells: evidence of a functional and physical coupling , 2013, Journal of neurochemistry.

[174]  F. Chaudhry,et al.  Protein Kinase C Phosphorylates the System N Glutamine Transporter SN1 (Slc38a3) and Regulates Its Membrane Trafficking and Degradation , 2013, Front. Endocrinol..

[175]  D. Pow,et al.  Excitatory Amino Acid Transporter 5 is widely expressed in peripheral tissues , 2013, European journal of histochemistry : EJH.

[176]  V. Jacobs,et al.  Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model , 2013, Journal of Neuro-Oncology.

[177]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.